H U Group Holdings: Short message of Q1 financial results for March 2025 (consolidated, Japanese standard).
H U Group Holdings: Partnership for the development of blood-based diagnostic reagents for Alzheimer's disease with biogen and Beckman Coulter.
H U Group Holdings: Corporate Governance Report
H U Group Holdings: Report on Corporate Governance, June 28th, 2024.
H U Group Holdings: H.U. Group Holdings continues to be selected as a constituent stock of the FTSE Blossom Japan Index and the FTSE Blossom Japan Sector Relative Index.
H U Group Holdings: Continued selection of constituent stocks for the FTSE Blossom Japan Index and the FTSE Blossom Japan Sector Relative Index.
H U Group Holdings: Change report (exemption share certificates, etc.)
H U Group Holdings: Extraordinary Report
H U Group Holdings: Internal Control Report - 74th Term (2023/04/01 - 2024/03/31)
H U Group Holdings: Confirmation letter
H U Group Holdings: Securities Report - 74th Fiscal Year (April 1, 2023 - March 31, 2024)
H U Group Holdings: msci inc received the highest rank of "AAA" for three consecutive years in the ESG rating.
H U Group Holdings: For three consecutive years, MSCI Inc has received the highest rank of AAA in MSCI ESG ratings.
H U Group Holdings: Selected as Digital Transformation Stock (DX Stock) for 2 consecutive years
H U Group Holdings: Selection for the 2nd year in a row as a “DX Brand”
H U Group Holdings: Independent Officer Notification Form
H U Group Holdings: Notice of the 74th Annual General Meeting of Shareholders
H U Group Holdings: 74th Annual General Meeting of Shareholders General Shareholders Meeting Materials (matters omitted from the notice of convocation)
H U Group Holdings: Notice of Convocation of the 74th Annual General Meeting of Shareholders and Shareholders' Meeting Materials
H U Group Holdings: Notice regarding dividends from surplus funds
No Data